磁共振引导下的立体定向体放射治疗肾细胞癌胰腺寡转移瘤。

IF 3.4 Q2 ONCOLOGY

Physics and Imaging in Radiation Oncology Pub Date : 2024-10-01 DOI:10.1016/j.phro.2024.100683

Jonna K. van Vulpen , Hidde Eijkelenkamp , Guus Grimbergen , Frank J. Wessels , Sasja F. Mulder , Gert J. Meijer , Martijn P.W. Intven

{"title":"磁共振引导下的立体定向体放射治疗肾细胞癌胰腺寡转移瘤。","authors":"Jonna K. van Vulpen , Hidde Eijkelenkamp , Guus Grimbergen , Frank J. Wessels , Sasja F. Mulder , Gert J. Meijer , Martijn P.W. Intven","doi":"10.1016/j.phro.2024.100683","DOIUrl":null,"url":null,"abstract":"<div><div>Stereotactic body radiation therapy (SBRT) may be a non-invasive strategy to treat patients with pancreatic oligometastases from renal cell carcinoma (RCC). We analyzed 11 patients treated with MR-guided SBRT to 31 pancreatic oligometastases. At a median follow-up of 31.6 months, 1-year and 2-year freedom from local progression was 100 % and 95 % (95 % CI 86–100 %), respectively. Moreover, 1-year and 2-year freedom from systemic therapy was 91 % (95 %CI 75–100 %) and 82 % (95 % CI 62–100 %), respectively. MR-guided SBRT may be a safe and effective treatment option for pancreatic oligometastases from RCC.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"32 ","pages":"Article 100683"},"PeriodicalIF":3.4000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11650256/pdf/","citationCount":"0","resultStr":"{\"title\":\"Magnetic resonance-guided stereotactic body radiation therapy for pancreatic oligometastases from renal cell carcinoma\",\"authors\":\"Jonna K. van Vulpen , Hidde Eijkelenkamp , Guus Grimbergen , Frank J. Wessels , Sasja F. Mulder , Gert J. Meijer , Martijn P.W. Intven\",\"doi\":\"10.1016/j.phro.2024.100683\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Stereotactic body radiation therapy (SBRT) may be a non-invasive strategy to treat patients with pancreatic oligometastases from renal cell carcinoma (RCC). We analyzed 11 patients treated with MR-guided SBRT to 31 pancreatic oligometastases. At a median follow-up of 31.6 months, 1-year and 2-year freedom from local progression was 100 % and 95 % (95 % CI 86–100 %), respectively. Moreover, 1-year and 2-year freedom from systemic therapy was 91 % (95 %CI 75–100 %) and 82 % (95 % CI 62–100 %), respectively. MR-guided SBRT may be a safe and effective treatment option for pancreatic oligometastases from RCC.</div></div>\",\"PeriodicalId\":36850,\"journal\":{\"name\":\"Physics and Imaging in Radiation Oncology\",\"volume\":\"32 \",\"pages\":\"Article 100683\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11650256/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Physics and Imaging in Radiation Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405631624001532\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physics and Imaging in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405631624001532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

立体定向全身放射治疗（SBRT）可能是治疗肾细胞癌（RCC）胰腺少转移患者的一种非侵入性策略。我们分析了11例接受mr引导的SBRT治疗的31例胰腺少转移灶。在中位31.6个月的随访中，1年和2年的局部进展自由度分别为100%和95% （95% CI 86- 100%）。此外，1年和2年的全身治疗自由度分别为91% （95% CI 75- 100%）和82% （95% CI 62- 100%）。mr引导下的SBRT可能是一种安全有效的治疗RCC胰腺少转移的选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Magnetic resonance-guided stereotactic body radiation therapy for pancreatic oligometastases from renal cell carcinoma

Stereotactic body radiation therapy (SBRT) may be a non-invasive strategy to treat patients with pancreatic oligometastases from renal cell carcinoma (RCC). We analyzed 11 patients treated with MR-guided SBRT to 31 pancreatic oligometastases. At a median follow-up of 31.6 months, 1-year and 2-year freedom from local progression was 100 % and 95 % (95 % CI 86–100 %), respectively. Moreover, 1-year and 2-year freedom from systemic therapy was 91 % (95 %CI 75–100 %) and 82 % (95 % CI 62–100 %), respectively. MR-guided SBRT may be a safe and effective treatment option for pancreatic oligometastases from RCC.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Physics and Imaging in Radiation Oncology Physics and Astronomy-Radiation

CiteScore

5.30

自引率

18.90%

发文量

审稿时长

6 weeks